Related Experiment Video
Updated: Aug 29, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
Bao-Zhu Yuan1, Amy M Jefferson, Kimberly T Baldwin
1Laboratory of Genetic Susceptibility, Toxicology and Molecular Biology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA. bby1@cdc.gov
Abstract:
The deleted in liver cancer (DLC-1) gene at chromosome 8p21-22 is altered mainly by genomic deletion or aberrant promoter methylation in a large number of human cancers such as breast, liver, colon and prostate and is known to have an inhibitory effect on breast and liver tumor cell growth. Given the high frequency of deletion involving region 8p21-22 in human non-small cell lung carcinoma (NSCLC), we examined alterations of DLC-1 in a series of primary tumors and tumor cell lines and tested effects of DLC-1 on tumor cell growth. A significant decrease or absence of the DLC-1 mRNA expression was found in 95% of primary NSCLC (20/21) and 58% of NSCLC cell lines (11/19). Transcriptional silencing of DLC-1 was primarily associated with aberrant DNA methylation, rather than genomic deletion as 5-aza-2'-deoxycytidine induced reactivation of DLC-1 expression in 82% (9/11) NSCLC cell lines showing downregulated DLC-1. It was further evidenced by an aberrant DLC-1 promoter methylation pattern, which was detected by Southern blotting in 73% (8/11) of NSCLC cell lines with downregulation of the gene. The transfer of DLC-1 into three DLC-1 negative cell lines caused a significant inhibition in cell proliferation and/or a decrease in colony formation. Furthermore, stable transfer of DLC-1 abolished tumorigenicity in nude mice of two cell lines, suggesting that DLC-1 plays a role in NSCLC by acting as a bona fide new tumor suppressor gene.
Insights
The Deleted in Liver Cancer (DLC-1) gene is frequently silenced in non-small cell lung carcinoma (NSCLC) primarily through DNA methylation. Restoring DLC-1 expression inhibits NSCLC cell growth and tumorigenicity, identifying it as a tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The Deleted in Liver Cancer (DLC-1) gene, located at chromosome 8p21-22, is known to suppress tumor growth in breast and liver cancers.
- Genomic alterations, including deletion and promoter methylation, frequently affect DLC-1 in various human cancers.
- The 8p21-22 region is often deleted in non-small cell lung carcinoma (NSCLC), suggesting a potential role for DLC-1 in lung tumorigenesis.
Purpose of the Study:
- To investigate alterations of the DLC-1 gene in non-small cell lung carcinoma (NSCLC).
- To determine the mechanism of DLC-1 downregulation in NSCLC.
- To evaluate the functional role of DLC-1 as a tumor suppressor in NSCLC.
Main Methods:
- Analysis of DLC-1 mRNA expression in primary NSCLC tumors and cell lines.
- Assessment of genomic deletion and promoter methylation as mechanisms for DLC-1 silencing.
- Treatment of NSCLC cell lines with 5-aza-2'-deoxycytidine to induce DLC-1 reactivation.
- Southern blotting to detect aberrant DLC-1 promoter methylation.
- Gene transfer experiments to restore DLC-1 expression in NSCLC cells.
- In vivo tumorigenicity assays in nude mice.
Main Results:
- A significant decrease or absence of DLC-1 mRNA expression was observed in 95% of primary NSCLC and 58% of NSCLC cell lines.
- Aberrant DNA methylation was identified as the primary mechanism for DLC-1 transcriptional silencing in NSCLC, with reactivation observed in 82% of cell lines after 5-aza-2'-deoxycytidine treatment.
- Aberrant DLC-1 promoter methylation was detected in 73% of NSCLC cell lines with downregulated DLC-1.
- Restoration of DLC-1 expression in DLC-1-negative NSCLC cell lines significantly inhibited cell proliferation and colony formation.
- Stable transfer of DLC-1 abolished tumorigenicity in nude mice for two tested cell lines.
Conclusions:
- DLC-1 is frequently downregulated in non-small cell lung carcinoma (NSCLC), primarily due to aberrant promoter methylation.
- DLC-1 functions as a bona fide tumor suppressor gene in NSCLC, inhibiting cell proliferation, colony formation, and tumorigenicity.
- Restoring DLC-1 expression represents a potential therapeutic strategy for NSCLC.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
lncRNA - Long Non-coding RNAs